Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.

AusPAR: Aflibercept (rch)

Australian Public Assessment Report

AusPAR

AusPAR: Aflibercept (rch) [PDF, 1.68 MB]

AusPAR: Aflibercept (rch) [Word, 1.33 MB]

Attachment: Product Information: Alibercept (rch) [PDF, 583.87 KB]

Attachment: Product Information: Alibercept (rch) [Word, 621.98 KB]

Attachment: Extract from the Clinical Evaluation Report: Aflibercept (rch) [PDF, 1.95 MB]

Attachment: Extract from the Clinical Evaluation Report: Aflibercept (rch) [Word, 2.14 MB]

Device/Product Name

Eylea

Active ingredients

Aflibercept (rch)

AusPAR Date

4 August 2014

Published

25 August 2014

Submission Number

PM-2012-03146-3-5

Submission Type

Extension of indications, Changes to Product Information

Decision

Approved